PCBL Chemical Limited Holds 65th AGM; Approves Financials & Re-appoints Director
PCBL Chemical Limited held its 65th AGM on September 22, 2026. The company approved its FY26 financial statements and confirmed the interim dividend of 600%. Dr. Sanjiv Goenka was re-appointed as Director. The Chairman highlighted capacity expansions and a new battery chemicals plant.
The re-appointment of a director and approval of financial statements are routine for an AGM. However, the Chairman's positive outlook on capacity expansion, margin improvement, and the potential of the new battery chemicals plant indicates a medium-term positive outlook for the company's business.
The AGM proceedings were positive, with strong shareholder approval for financial statements, dividends, and director re-appointments. Management commentary focused on positive future outlook and strategic growth initiatives.
PCBL Chemical Limited conducted its 65th Annual General Meeting (AGM) on September 22, 2026, via Video Conferencing. The meeting commenced at 11:30 A.M. (IST) and concluded at 12:05 P.M. (IST).
During the AGM, shareholders approved the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, along with the Board and Auditors' reports. The interim dividend of 600% (₹6.00 per equity share) paid for the Financial Year 2025-26 was also confirmed.
Dr. Sanjiv Goenka was re-appointed as a Director of the Company, retiring by rotation. Furthermore, the remuneration of M/s. Shome & Banerjee, Cost Accountants, for the financial year ending March 31, 2027, was ratified.
The Chairman, Dr. Sanjiv Goenka, addressed the members, highlighting that while the past year was challenging, the current year shows promise due to internal changes, transformation, improved capacity utilization, and enhanced R&D, which are expected to improve margins. The company is expanding capacities in commodity and specialty blacks, and chemicals, with a shift towards value-added products. The development of a battery chemicals plant was also mentioned as a potentially significant bottom-line accretive business upon operationalization.
Members raised queries regarding growth strategy, impact of geopolitical tensions on supply chains, entry into new segments, ESG strategy, AI integration, cybersecurity, Aquapharm business updates, and R&D initiatives. The Chairman provided comprehensive responses to these queries.
The voting results for all resolutions were declared on September 22, 2026, and will be disseminated to the stock exchanges and posted on the company's website. The voting results showed overwhelming support for all resolutions, with over 99% of votes in favor.
What to do with a filing like this
PCBL Chemical Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by PCBL Chemical Limited. Read the original for the full detail.